소개글
[경영학]ELI LILLY(일라이 릴리)의 사례연구(영문)에 대한 자료입니다.
목차
1.History
2.Eli Lilly and Company Major Product
3I.nnovation in the new drug development process
4.Combinatorial chemistry
5.Combinatorial chemistry at Lilly
6.Drug discovery for central nervous system (cns) diseases
7.Lilly’s migraine project
본문내용
Many CNS diseases were thought to result from imbalances of neurotransmitters. Different neurotransmitters were known to activate different receptors just as different keys might open up different doorways.
Various classes of neurotransmitters, such as dopamine, norepinephrine, and serotonin, were associated with differing diseases. For example, Serotonin was associated with a variety of conditions ranging from depression to insomnia to aggression to migraine.
Lilly’s first billion dollar blockbuster antidepressant drug, Prozac® very selectively boosted levels of serotonin to exert its therapeutic effects.
Prozac® had undesirable side-effects such as sedation, anxiety, and dry mouth.
Prozac® would come off patent in 2003